Insulet | الدائنين التجاريين



Trade Creditors تغيير تاريخ
Abbott USD 4.21B 7.48B 2025-03
Align Technology USD 125.38M 16.69M 2025-03
AtriCure USD 25.18M 144K 2025-03
Avanos Medical USD 46M 8.3M 2025-03
Baxter International USD 968M 127M 2024-12
Becton, Dickinson and Co. USD 1.9B 255M 2024-09
Boston Scientific USD 1B 44M 2025-03
Cardinal Health USD 32.81B 1.51B 2025-03
Cooper Companies USD 244.2M 42.7M 2025-04
Dexcom USD 432M 86.7M 2025-03
Edwards Lifesciences USD 172.4M 25M 2025-03
Eli Lilly USD 3.44B 213.4M 2025-03
Globus Medical USD 73.14M 1.97M 2025-03
ICU Medical USD 180.41M 32.39M 2025-03
Insulet USD 57.6M 37.8M 2025-03
Integra LifeSciences USD 91.3M 8.79M 2025-03
J&J USD 9.54B 766M 2025-03
Masimo USD 124.9M 127.9M 2025-03
Medtronic USD 2.45B 163M 2025-04
Merit Medical Systems USD 63.76M 4.74M 2025-03
Roche Holding 4.35B 828M 2024-12
Solventum Corp 604M 14M 2025-03
Stryker USD 1.46B 215M 2025-03
Tandem Diabetes Care USD 59.8M 15.07M 2025-03
Teleflex USD 143.04M 2.01M 2025-03
West Pharmaceutical Services USD 239M 10.6M 2025-06
Zimmer Biomet Holdings USD 194.6M 127.8M 2024-12


Insulet الدائنين التجاريين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.